HuntDiseaseFAQS

Cognitive Testing Detects Early Huntington's Disease
Home
Index
GENETIC TESTING INFO
EARLY HD
MEDICATIONS~DRUGS
Movement Disorder Medicines
Anxiety-Antidepressant Medications
Antidepressant Adverse Effects
Warnings~Adolescents Under 25
Sertraline ~Zoloft
SSRI's
Anti-psychotic Medications
Prozac, Luvox, Paxil, Zoloft & Celexa
Olanzipine & Risperidone and blood tests
Creatine
Drugs~General
Cutting Prescriptions
Sites That Help the Medicine Go Down
Vitamins & Minerals
SYMPTOMS
Why Certain Symptoms Occur In HD
Tests Commonly Used -Neuropsychological Examination
Symptom vs Medication
HD-Disability
HD~Communications
Speech & Swallowing Difficulties~Lynn Rhodes
Swallowing Problem Warning Signs
Swallowing Tests
Nutrition and HD~Anna Gaba (Recipes)
HD & Diet~HSA Fact Sheet 7
HD~Swallowing & Nutrition
Weight Gain
Taste
5 Levels Difficulty In Swallowing
Feeding Tube~Advanced Stages of HD
Feeding Tube~Jean Miller
One more word on feeding tubes
PEG Tubes and baby foods
Feeding Tubes-More Info
Dehydration
HD~Chorea
HD~Falling/Safety Issues
HD~Cognitive/Decision Making/Impulsivity
Cognitive-Short Tips
HD-Apathy
HD~Perceptual/Unawareness/Attention
Denial of HD
HD~Irritability/Temper Outbursts
Managing behavioral problems
HD~Depression
Depression - Treatment Resistant Patient
HD~Anxiety/Apathy/Irritability
HD~Mania, Obsessive Disorders
HD~Hallucinations & Psychosis
HD~Rigidity, Spasticity, and Dystonia
HD~Seizure/Convulsion/Epilepsy/Tics
Nails
MISCELLANEOUS
Adaptive Products
HD~Suicide
Teen Suicide~Let's Talk Facts
HD~Incontinence
Stress Explained-Easy/Fun Format
How To Help Someone Chronically Ill
Legal Planning for Incapacity
Out-of-Home Care Options FAQ
Preparing for Emergencies
 
Cognitive Testing Detects Early Huntington's Disease
 WESTPORT, CT (Reuters Health) Sept 05 2001 - "Early signs of Huntington's disease can be detected using neuropsychological measures 2 years before the development of more manifest motor disease," Dr. Jane S. Paulsen of the University of Iowa, Iowa City, tells Reuters Health.

She and colleagues with the Huntington Study Group note in the August 28th
issue of Neurology that "there is increasing evidence that neuron loss precedes the phenotypic expression of HD."
 
To investigate, they used the Unified Huntington's Disease Rating Scale (UHDRS) to prospectively study 260 patients who had a parent with the disease.


The subjects did not have manifest disease at baseline. "Repeat UHDRS data, obtained an average of 2 years later, showed that 70 persons were given a diagnosis of definite HD based on the quantified neurologic examination," according to the report.
 
Patients who did not show manifest disease during the followup period
showed improvement on all cognitive tests. In contrast, patients who showed conversion to disease during the followup demonstrated a decline in every cognitive area. "All of the change rates remained significantly different for converters and nonconverters (all p < 0.001)."

"Accurate and early detection of mid-and late-life diseases is becoming more and more important as therapeutic options to slow disease progression or delay disease onset are identified," Dr. Paulsen noted.

Neurology 2001;57:658-662.